An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes**

By Stanford Richard H.   Fuhlbrigge Anne   Riedel Aylin   Rey Gabriel Gomez   Stempel David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3141-3148

Informa Healthcare

Access to resources Recommend Favorite

Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids

By Friedman Howard S.   Yawn Barbara P.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 427-434

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma

By Doull Iolo   Price David   Thomas Mike   Hawkins Neil   Stamuli Eugena   Tabberer Maggie   Gosden Toby   Rudge Helen  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1147-1159

Informa Healthcare

Access to resources Recommend Favorite

Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone

By Bailey William   Castro Mario   Matz Jonathan   White Martha   Dransfield Mark   Yancey Steve   Ortega Hector  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1669-1682

Informa Healthcare

Access to resources Recommend Favorite

Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma

By Dunlop William   Heron Louise   Fox Georgia   Greaney Maire  

Advances in Therapy, Vol. 30, Iss. 10, 2013-10 ,pp. : 933-944

Springer Publishing Company

Access to resources Recommend Favorite